Search Results for "CT P6 Celltrion"

01:07 EDT 1st October 2016 | BioPortfolio

Matching Channels


Matching News

Real-world biosimilar data driving physician acceptance, says Celltrion

Biosimilar acceptance among physicians has doubled to 80% since 2013, according to a survey presented at by copycat biologic distributor Celltrion Healthcare.

Inside Celltrion: a biosimilar success story built on landfill

Ambition, hard work and a focus on quality has made Celltrion the ‘pioneers of the mAb biosimilar industry,’ the firm told Biopharma-Reporter during a tour of its biomanufacturing site in Songdo, ...

Pfizer introduces first and only biosimilar monoclonal antibody therapy

Michael JohnsenHospira, now a Pfizer company, entered into an agreement with Celltrion and Celltrion Healthcare in 2009 for several potential biosimilar products, including the recently-approved Infle...

Celltrion's biosimilar for J&J’s arthritis drug gets UF FDA okay

Korea-based Celltrion (Kosdaq: 068270) has received US regulatory approval for its biosimilar version of the arthritis drug marketed by Johnson & Johnson (NYSE: JNJ) and Merck & Co (NYSE: MRK)...

Celltrion/Pfizer Agree To Wait For Mid-September Inflectra Launch

Celltrion Inc. and Pfizer Inc., who have been waiting to launch their biosimilar Inflectra (infliximab-dyyb) pending an ongoing legal dispute...  

Celltrion/Pfizer's Biosimilar Launch: Three Possible Dates For Inflectra

Pfizer and Celltrion still face patent questions – and a pesky launch notification issue – after the ground-breaking US approval of their biosimilar version of Janssen's Remicade.

Many Firsts As Celltrion/Pfizer’s Inflectra Becomes Second US Biosimilar

Move over Zarxio, there's a new kid in town: Inflectra (infliximab-dyyb), which won the FDA's nod on April 5 as the first monoclonal antibody biosimilar licensed in the US, although it's going to be a...

Inflectra-maker Celltrion to expand biosimilar capacity by 170,000L

Celltrion will invest $275m at its biosimilar production site in Korea to ramp up capacity from 140,000L to 310,000L by 2021.

Matching PubMed Articles

Search Whole site using Google

Quick Search
Advertisement Advertisement